D Taylor1. 1. Pharmacy Department, Maudsley Hospital and Division of Pharmaceutical Sciences, King's College, London, UK. david.taylor@slam.nhs.uk
Abstract
OBJECTIVE: To review data examining the relationships between depression, antidepressants and cardiovascular disease. METHOD: Structured searches of PubMed, Medline and Embase conducted in March 2008. RESULTS: Depression and cardiovascular disease are closely associated clinical entities. Depression appears both to cause and worsen cardiovascular disease. Cardiovascular disease is in turn associated with a high incidence of depression. Depression is associated with increased mortality in cardiovascular disease, and after myocardial infarction (MI) and stroke. Many antidepressants have cardiotoxic properties. Tricyclic drugs are highly cardiotoxic in overdose and may induce cardiovascular disease and worsen outcome in established cardiovascular disease. Reboxetine, duloxetine and venlafaxine are known to increase blood pressure. Other antidepressants have neutral or beneficial effects in various cardiovascular disorders. CONCLUSION: Sertraline, fluoxetine, citalopram, bupropion and mirtazapine appear to be safe to use after MI; the use of sertraline, and response to citalopram and mirtazapine may improve mortality. Paroxetine and citalopram appear to be safe to use in patients with established coronary artery disease. Limited data suggest that a variety of antidepressants are effective and safe to use after stroke.
OBJECTIVE: To review data examining the relationships between depression, antidepressants and cardiovascular disease. METHOD: Structured searches of PubMed, Medline and Embase conducted in March 2008. RESULTS:Depression and cardiovascular disease are closely associated clinical entities. Depression appears both to cause and worsen cardiovascular disease. Cardiovascular disease is in turn associated with a high incidence of depression. Depression is associated with increased mortality in cardiovascular disease, and after myocardial infarction (MI) and stroke. Many antidepressants have cardiotoxic properties. Tricyclic drugs are highly cardiotoxic in overdose and may induce cardiovascular disease and worsen outcome in established cardiovascular disease. Reboxetine, duloxetine and venlafaxine are known to increase blood pressure. Other antidepressants have neutral or beneficial effects in various cardiovascular disorders. CONCLUSION:Sertraline, fluoxetine, citalopram, bupropion and mirtazapine appear to be safe to use after MI; the use of sertraline, and response to citalopram and mirtazapine may improve mortality. Paroxetine and citalopram appear to be safe to use in patients with established coronary artery disease. Limited data suggest that a variety of antidepressants are effective and safe to use after stroke.
Authors: Matthew J Czarny; Erin Arthurs; Diana-Frances Coffie; Cheri Smith; Russell J Steele; Roy C Ziegelstein; Brett D Thombs Journal: PLoS One Date: 2011-11-22 Impact factor: 3.240
Authors: Erica B Royster; Lisa M Trimble; George Cotsonis; Brian Schmotzer; Amita Manatunga; Natasha N Rushing; Giuseppe Pagnoni; S Freda Auyeung; Angelo R Brown; Joel Schoenbeck; Smitha Murthy; William M McDonald; Dominique L Musselman Journal: Cardiovasc Psychiatry Neurol Date: 2012-08-27